An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)
NCT07404644
·
clinicaltrials.gov ↗
RECRUITING
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Von Willebrand Disease (vWD)
Interventions
DRUG:
vonicog alfa (rVWF)
Sponsor
Takeda